openPR Logo
Press release

Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024

11-24-2017 06:25 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Dental Membrane and Bone Graft Substitutes Market to rise to US$

Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.

The global dental membrane and bone graft substitutes market is expected to rise from a value of US$419 mn in 2015 to US$922.6 mn by 2024. If these values hold true, the market is expected to exhibit a strong CAGR of 9.3% during the forecast period.

Read Report Overview @ www.transparencymarketresearch.com/dental-membrane-bone-g...

Bone graft substitutes formed the leading product segment, accounting for a whopping 94.8% market share in 2015. Xenograft was the dominant sub-segment in 2015. Dental membranes, however, are expected to register a CAGR of 10.1% from 2016 to 2024, emerging as a highly lucrative investment option. By material, human cells sources hold the dominant share, while collagen is projected to witness strong growth in the near future.

Dental clinics are the leading as well as most promising end users of dental membranes and bone graft substitutes. Europe held the major share of 27.8% in the dental membrane and bone graft substitutes market in 2016. Asia Pacific, on the other hand, is projected to be a rapidly growing market, registering a CAGR of 11.0% from 2016 to 2024.

The rapid growth of dental tourism across developing countries such as Hungary, Mexico, China, and India has resulted in the availability of cost-effective and quality dental services. Healthy Travel Media, a leading publishing house in the U.S., finds that developing nations offer dental services at a cost that is 50% to 80% lower than that in developed countries such as the U.S. This has resulted in a surge in dental procedures across the globe, thereby fueling the demand for dental membranes and bone graft substitutes.

“Innovation in bone graft techniques is also a key factor driving this market,” the author of the study says. Advanced techniques such as xenograft and demineralized bone matrix have gained preference among patients in recent times owing to the several benefits they offer. Bone grafting is a procedure performed to replace a missing bone in a patient. Ideally, bone grafts are autologous, which means that the bone is harvested from the patient’s own body. This can be an extremely complex and risky procedure. Moreover, there is an acute shortage of donors. The development of xenografts allows bone substitutes to be taken from non-human species, such as bovine or natural coral, which addresses this shortage and also serves as a preferred options for people suffering from heart and kidney ailments.

Request Sample Report @ www.transparencymarketresearch.com/sample/sample.php?flag...

The global market for dental membrane and bone graft substitutes is rather fragmented, with the top four companies accounting for 30.0% in 2015. DENTSPLY International, Inc., Zimmer Biomet Holdings, Inc., Institut Straumann AG, and Integra LifeSciences Holdings Corporation presently dominate the global scene.

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024 here

News-ID: 831093 • Views: 406

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
Allergy Diagnostics Market is Projected to be Worth US$ 3.8 Billion by 2024
The opportunity presented by the global market was pegged at US$1.3 bn in 2015 and is projected to be worth US$3.8 bn by 2024, expanding at a strong CAGR of 12.8% therein. The consumables segment accounted for the major share in the allergy diagnostics market. The segment is projected to present a 50.1% share by 2024, registering the highest CAGR of 13.6% during the forecast period. The instruments segment, on the

All 5 Releases


More Releases for Bone

Bone Implant Market Gaining Momentum Worldwide - CT-Bone, 3D printed Bone Implan …
Market Highlights Bone implant products are used in numerous orthopedic surgeries to support the bone and to restore the functionality of the bone. The increasing geriatric population, growing number of orthopedic surgical procedures, rising prevalence of sports-related injuries, and bone weakness due to the changing lifestyle are the major factors driving the growth of the global bone implant market. Additionally, aggressive strategies adopted by top players and increasing spending on healthcare
Bone Fixation Screw Market
Global Bone Fixation Screw Market Research Report 2018 https://www.qandqmarketresearch.com/reports/bone-fixation-screw-market-26 This report studies the global Bone Fixation Screw market status and forecast, categorizes the global Bone Fixation Screw market size value & volume by key players, type, application, and region. This report focuses on the top players in North America, Europe, AsiaPacific, South America, and Middle East & Africa. Bone fixation is a surgical procedure that stabilizes and fix bone grafts and bone filling
Bone Replacement Products Market– Effective Solution for Bone Problems
The innovative replacement systems are designed to provide patients with a joint preservation ultimatum, preserving the healthy parts of the knee, thus helping to maintain natural knee function. For instance, in 2014, Cayenne Medical launched the Mirror Partial Knee System, the only knee replacement system that uses the patient’s natural knee motion during the surgical procedure. This unique technology balances the knee throughout the entire range of motion. The
Global Bone Glue Market| MarketResearchReports.biz
Latest industry research report on: Global Bone Glue Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Persistence Market Research presents an all-encompassing study of the global bone glue market titled Global Market Study on Bone Glue: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected to Boost Demand for Bone Glue over the Forecast Period . This study demonstrates the market dynamics and trends globally
Bone Degeneration Therapeutics Market
Bone degeneration is characterized by deterioration of articular cartilage covering the joints. Cartilage aids free movement of the joint without any resistance. Reduction in flexibility of the joint due to deterioration of cartilage leads to inflammation, compressed nerves, and pain. Aging is one of the natural causes of bone degeneration, which is also fueled by several conditions such as injuries, congenital disorders, diabetes, and obesity. Symptoms of degenerative bone disorders
Bone Cancer Treatment Market
Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manner. This growth may be benign or malignant. In most cases bone cancer results from other cancers such as lung cancer, kidney cancer, prostate cancer, and breast cancer,